The most remarkable result of our work is the data of PAPP-A in Colombian women who developed PE, not only because it seems that there is no statistical significance compared to women who did not develop any impaired placentation disease but because the mean value of PAPP-A in these patients are upper than the mean value of patients without adverse outcomes. Here, PAPPA is linked to placenta disorder.